CYP2C6 Antibodies

Santa Cruz Biotechnology features a diverse variety of CYP2C6 monoclonal antibodies for advanced research in pharmacology and toxicology. CYP2C6 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2C6 is a member of the cytochrome P450 family of enzymes, which play a crucial role in the metabolism of a wide range of drugs and xenobiotics. Understanding CYP2C6 function is essential for elucidating drug interactions and individual variations in drug metabolism, which can significantly impact therapeutic outcomes. The study of CYP2C6 is particularly important for personalized medicine, as variations in expression and activity can influence drug efficacy and safety. Research focused on CYP2C6 continues to reveal new insights into drug metabolism pathways and potential therapeutic targets. Investigating CYP2C6 expression patterns helps identify factors that affect drug response and metabolism across different populations. Santa Cruz Biotechnology monoclonal antibodies for CYP2C6 enable researchers worldwide to advance scientific understanding of drug metabolism and its impact on human health.